Microbiology of postoperative infections

Surgical Infections

Volumn 7, Issue SUPPL. 2, 2006, Pages

  Toniolo, Antonio ^a   Endimiani, Andrea ^a   Luzzaro, Francesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOCHEMISTRY; CANDIDA ALBICANS; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME KINETICS; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GRAM NEGATIVE BACTERIUM; HUMAN; HYBRIDIZATION; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; NONHUMAN; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; SURGICAL PATIENT; URINARY TRACT INFECTION;

EID: 33748052668     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.s2-13     Document Type: Article

References (16)

1. Carmeli Y, Troillet N, Karchmer AW, Samore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999;159:501-509.
2. Cosgrove SE, Qi Y, Kayes KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-174.
3. Nichols RL. Preventing surgical site infections: A surgeon's perspective. Emer Infect Dis 2001;7:220-224.
4. Kernodle DS, Kaiser AB. Postoperative infections and antimicrobial prophylaxis. In Mandell GL, Bennett JE, Doli R, eds. Principles and Practice of Infectious Diseases, 5th ed. New York: Churchill Livingstone, 2000: 3177-3191.
5. Endimiani A, Tamborini A, Luzzaro F, et al. A two-year analysis of risk factors and outcome in patients with bloodstream infection. Jpn J Infect Dis 2003; 56:1-7.
6. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003;36:1433-1437.
7. Endimiani A, Luzzaro F, Perilli M, et al. Bacteremia due to a clonal strain of Klebsiella pneumoniae producing the TEM-52 extended-spectrum β-lactamase: Treatment outcome of patients receiving either imipenem or ciprofloxacin. Clin Infect Dis 2004;38:243-251.
8. Endimiani A, Luzzaro F, Brigante G, et al. Blood-stream infection due to Proteus mirabilis strains: Risk factors and treatment outcome associated with the expression of extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005;49:2598-2605.
9. Luzzaro F, Docquier JD, Colinon C, et al. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob Agents Chemother 2004;48:648-650.
10. Perilli M, Dell'Amico E, Segatore B, et al. Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002;40:611-614.
11. Luzzaro F, Perilli M, Dell'Amico E, et al. Extended-spectrum beta-lactamases in isolates of Enterobacteriaceae from inpatients and outpatients in northern Italy. Presented as Poster no. 754 at the 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, 1-4 May 2004.
12. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18:657-686.
13. Spanu T, Luzzaro F, Perilli M, et al. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002;46:196-202.
14. Brigante G, Luzzaro F, Perilli M, et al. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 2005;25:157-162.
15. Luzzaro F, Endimiani A, Docquier JD, et al. Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 2004;48:131-135.
16. Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PloS Genet 2006;13:2-7.